Please login to the form below
Sartorius promotes Stefan Schlack to senior VP of marketing
He will oversee marketing and product management at the pharma and biotech supply company
German pharma and biotech supply company Sartorius Stedim Biotech has promoted Stefan Schlack to senior vice president of marketing.
He has worked for Sartorius since 1996, beginning his career as a sales rep, and was most recently group vice president of global pharma key account management.
In his new role Schlack will have responsibility for all marketing and product management activities at the company.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Manager
-
Salary TBC
-
Planner
-
Salary TBC
-
Publications Director
-
Competitive Salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO
- Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women'
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- FDA advisory committee overwhelmingly votes no on Biogen's aducanumab
- BeiGene’s reveals positive data for Brukinsa in head-to-head Imbruvica trial
- BMS, Acceleron’s Reblozyl shows new improvements for beta thalassemia patients
- Biogen reports new data backing long-term benefit of Spinraza
- G7 expected to donate one billion COVID-19 vaccine doses
- Anna Korving joins Resonant Group as non-executive director
- Resonant Group appoints Stephen Marchant as chief development officer
- Novo Nordisk says Victoza outperforms SGLT2 inhibitors
- Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
- Nicky Hutchens appointed as deputy managing director at Four Health
- MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals
- AstraZeneca sets sights on China with Takeda deal
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
PMHub
Spirit
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...
Latest intelligence
- Article:
- The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
- The pursuit of patient diversity in clinical trials
- When all-inclusive isn’t an option, it’s an obligation...
- Overcoming the digital patient recruitment challenges of connecting with patients
- How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...
